The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Optical Genome Mapping Market Expected To Change Between 2026 And 2030?

The optical genome mapping market size has demonstrated rapid expansion in recent years. This market is projected to expand from $0.23 billion in 2025 to $0.29 billion in 2026, achieving a compound annual growth rate (CAGR) of 29.4%. Historically, this expansion has been driven by factors such as the constraints of next generation sequencing in detecting large structural variants, augmented genomic research funding, the escalating prevalence of genetic disorders, the rising demand for advanced cytogenetic techniques, and progress in imaging and DNA labeling technologies.

The optical genome mapping market size is projected to undergo substantial expansion in the coming years. It is anticipated to reach $0.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 25.9%. This projected growth throughout the forecast period stems from factors such as the increasing integration of OGM in clinical laboratories, rising investment in precision medicine initiatives, growing adoption of automated genomic analysis platforms, expanding applications in oncology and hematological malignancies, and the declining costs of genomic analysis technologies. Prominent trends for the forecast period include the growing adoption of optical genome mapping in structural variant detection, increasing use of OGM in rare disease and cancer research, rising demand for high-resolution long-read genomic analysis, the expansion of OGM applications in clinical diagnostics, and a growing preference for the complementary use of OGM with sequencing technologies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

Which Economic Or Industry Drivers Are Impacting The Optical Genome Mapping Market?

The growing need for precision medicine is anticipated to fuel the expansion of the optical genome mapping market moving ahead. Precision medicine represents a healthcare strategy that tailors medical treatments and preventative measures to unique individual attributes, including genetic composition, lifestyle choices, and environmental factors. The escalating prevalence of chronic illnesses, innovations in genomic technologies, heightened investment and financial backing, and patients’ desire for customized care are all contributing factors to the demand for precision medicine. optical genome mapping improves the effectiveness of precision medicine by offering a thorough and precise comprehension of genomic changes linked to different ailments. An example of this is seen in February 2024, where the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA sanctioned 16 new personalized treatments for individuals with rare conditions in 2023, an increase from six in 2022. Consequently, the escalating need for precision medicine is boosting the expansion of the optical genome mapping market.

How Is The Optical Genome Mapping Market Structured Across Different Segments?

The optical genome mapping market covered in this report is segmented –

1) By Product: Instruments, Consumables And Reagents, Software, Services

2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications

3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users

Subsegments:

1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices

2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells

3) By Software: Data Analysis Software, Image Processing Software, Mapping Software

4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services

What Industry Trends Are Redefining The Optical Genome Mapping Market?

Key players in the optical genome mapping (OGM) market are concentrating on creating technological innovations, particularly OGM-based laboratory-developed tests (LDTs), designed for comprehensive genome-wide structural variant identification. This aims to boost diagnostic precision, streamline operational processes, and lessen dependence on numerous conventional cytogenetic analyses. An OGM-based LDT utilizes extremely long, high-molecular-weight DNA molecules, which are fluorescently marked and straightened within nanochannels. This enables high-resolution imaging to detect insertions, deletions, translocations, and repeat expansions throughout the genome, features frequently overlooked by short-read sequencing or microarrays. As an example, in March 2023, Bionano Laboratories, a CLIA-certified U.S. subsidiary of Bionano Genomics, introduced its OGM Dx Postnatal Whole Genome SV test. This product facilitates the detection of structural variants across the entire genome in individuals experiencing developmental disorders, intellectual disability, autism spectrum disorder, epilepsy, or unconfirmed genetic conditions. It combines high-resolution OGM with variant calling within a unified test workflow, thereby minimizing the necessity for multiple traditional cytogenetic assays and offering quicker, more extensive diagnostic understanding.

Which Major Players Dominate The Optical Genome Mapping Market?

Major companies operating in the optical genome mapping market are Bionano Genomics Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., BioSkryb Genomics, Phase Genomics Inc., Nabsys, Daicel Arbor Biosciences, OpGen, Thermo Fisher Scientific Inc., Roche Sequencing Solutions, Genomic Vision SA, INRAE French Plant Genomic Resources Center, Source BioScience, Resolve Biosciences, Arima Genomics Inc., GnuBIO Inc., Longas Technologies, GE Healthcare Life Sciences, Danaher Corporation, Strand Life Sciences, Berry Genomics, Dante Genomics

Read the full optical genome mapping market report here:

https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

What Are The Top-Performing Regions Within The Optical Genome Mapping Market?

North America was the largest region in the optical genome mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Optical Genome Mapping Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15882&type=smp

Browse Through More Reports Similar to the Global Optical Genome Mapping Market 2026, By The Business Research Company

Optic Atrophy Management Global Market Report

https://www.thebusinessresearchcompany.com/report/optic-atrophy-management-global-market-report

Peripheral Neuropathy Global Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Diabetic Neuropathy Global Market Report

https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model